Gidsen 

What would count as a meaningful fine-line improvement?

A defensible claim identifies the location, the condition in which it was assessed and the size of the change. “Crow’s feet at rest improved on a blinded grading scale” is more informative than “skin looks younger.” For evidence of a treatment effect, ask whether the change was greater than in a suitable control group, rather than simply better than the starting photograph.

In this article, fine lines means shallow surface creases; deep folds means more pronounced grooves or folds. These are descriptive terms, not a universal study classification. A trial’s actual scale and enrollment criteria matter more than its use of the word “rejuvenation.” Lines assessed with a relaxed face are also a different endpoint from lines assessed while smiling. The newer crow’s-feet trial specifically assessed wrinkles at rest. [2]

Evidence for a local wrinkle endpoint does not establish repositioning of facial tissue, restoration of facial volume or correction of deep folds. Those claims require their own measurements. Likewise, a skin-density measurement cannot substitute for evidence that a particular visible line became less noticeable.

What each measurement tells you—and what it leaves unanswered

The strongest interpretation comes from looking at the endpoints together. An instrument can detect a change that a broad visual scale misses; a person can feel better about their appearance without a measurable change in wrinkle severity. Neither possibility lets a writer replace the actual finding with a stronger one.

These distinctions are illustrated by the different assessment methods used in the studies below. They are a framework for reading results, not a ranking in which an instrument automatically outranks a person’s experience. [1] [2] [3]

Three studies show why the endpoint matters

The 2025 frequency trial: positive results were selective

Bragato and colleagues studied 95 women aged 45–60 using a 660 ± 10 nm red LED mask. Over four weeks, two active groups received two or three weekly applications, with a sham comparison group. The publisher’s abstract reports no significant group differences on the Wrinkle Assessment Scale, rated by blinded specialists. ImageJ analysis found reduced wrinkle length in the glabellar and right periorbital regions compared with control; FACE-Q satisfaction also favored the active groups. [1]

The accurate interpretation is endpoint-specific: the photographic analysis and satisfaction findings were positive, while the specialist scale did not distinguish the groups. That does not establish that the treatments were identical or that no participant improved. It also does not support calling every facial region improved. The full article was not accessible for this review, so detailed effect sizes, all analyses and long-term durability remain unverified.

The tested frequencies describe this experiment, not a universal home-use schedule. A comparison within one protocol cannot prescribe settings for another mask.

The 2025 crow’s-feet trial: a responder is not a percentage of wrinkle removal

Park and colleagues studied adults of Asian descent aged 30–65 with Fitzpatrick skin types II–V and specified crow’s-feet severity at rest. The active mask combined 630 nm red LEDs and 850 nm infrared-emitting diodes. Its sham emitted lower-intensity red light without infrared. Methods describe 12 weeks of use and a further four weeks of follow-up. [2]

At week 12, independent evaluators classified 25 of 29 active-group participants (86.2%) and 5 of 30 controls (16.7%) as improved in the full analysis set. Improvement meant a decrease of at least one point on the crow’s-feet grading scale at rest. It did not mean an 86.2% reduction in wrinkle depth, or that wrinkles disappeared. [2]

This is evidence for a defined local endpoint with that combined device. It cannot isolate red light’s contribution from infrared, predict results from every mask or establish improvement in smiling lines or deep folds. The paper contains reporting inconsistencies, including summary wording about 16 weeks of use versus the methods’ 12-week treatment period. These limit confidence in an uncomplicated reading of its headline claims.

Commercial funding: The study was funded by Y&J Bio, the manufacturer of the experimental device. The authors state that study design, data collection, analysis, interpretation and manuscript writing were independent of the funder, and declare no conflicts of interest. This is the authors’ disclosure, not an external verification of independence or an assurance that bias is absent. [2]

The 2014 study: useful measurements, a different light source

Wunsch and Matuschka used large-area polychromatic gas-discharge lamps, rather than contemporary narrow-band LED masks. After 30 sessions, they reported improved blinded photographic assessments, periorbital surface roughness and ultrasound collagen-intensity measurements relative to untreated controls. Treatment groups were randomized, but the control group was recruited separately without randomization; there was no sham exposure. The sponsor funded the study and remunerated the investigators. [3]

The study illustrates why visible appearance, surface texture and a tissue-related marker should be separated. Its ultrasound outcome is not a biopsy measurement of newly produced collagen, and its findings do not validate all LED masks. The control design and commercial involvement are relevant limitations, alongside the different light source.

Averages, responder rates and visible benefit are different claims

A mean change describes the group average. It does not reveal whether responses were fairly similar or concentrated in a few participants. A responder rate counts people crossing a defined threshold. It says nothing about how far beyond that threshold each person went. A satisfaction score reports experience, not the fraction of wrinkles removed.

Before accepting a percentage, finish this sentence: “This is the percentage of ___, measured by ___, compared with ___, at ___.” If the blanks cannot be filled, the number is too ambiguous to guide expectations. The crow’s-feet result above can be filled in; a slogan such as “86% fewer wrinkles” cannot be substituted for it. [2]

Statistical significance addresses evidence of a difference under the analysis; it does not by itself say whether the change would matter to you in ordinary lighting. Look for the absolute change, the starting severity, uncertainty around the estimate and any stated threshold for meaningful improvement. Conversely, a nonsignificant result does not automatically prove equivalence. In a study with several outcomes, retain the null findings as well as the positive ones.

Common misconceptions: “More satisfied” does not mean “fewer wrinkles by the same percentage.” A measured reduction in length does not prove a reduction in depth. A positive result at one follow-up visit does not establish permanence. None of these studies provides an individual guarantee or demonstrates a facelift effect.

A practical checklist for evaluating a fine-line claim

1. Identify the target. Is it crow’s feet at rest, forehead lines, texture or overall satisfaction?
2. Name the measure. Look for the scale, imaging variable or questionnaire, not just “clinically tested.”
3. Read the comparison. Did the active group outperform a sham or untreated group? Was only its own baseline compared?
4. Check applicability. Match the studied light source, wavelengths, exposure geometry, population and baseline severity. A matching color alone is insufficient.
5. Keep the full outcome pattern. Note findings that were unchanged, regions that were not improved and follow-up limits.
6. Inspect the percentage. Separate average change, responders and satisfaction. Check the denominator and assessment time.

For personal documentation, keep camera position, lighting, facial expression and image processing consistent. Record changes in skincare or other treatments that could complicate interpretation. This can make comparisons more honest, but an uncontrolled home photo diary cannot prove that light caused a change. Do not add sessions to obtain a more dramatic photograph.

Further questions

Can two studies’ wrinkle percentages be compared directly?

Only after checking that they measure comparable outcomes with comparable definitions, controls and assessment times. A responder proportion on a grading scale cannot be ranked against a percentage change in image-based wrinkle length. Different device and population choices add further uncertainty.

Does a one-grade improvement mean a line is gone?

No. It means the assessment crossed a scale threshold. The starting grade and the scale’s category definitions determine what that change represents; complete disappearance is a separate claim. The Park trial counted at least one point of improvement rather than requiring wrinkle elimination. [2]

Can these results tell me how long my improvement will last?

They cannot provide a personal duration forecast. Treatment and observation periods are different, and short follow-up cannot establish lasting benefit. The Park methods describe follow-up only four weeks beyond the treatment period; longer-term outcomes remain uncertain. [2]

If I see no change, should I increase the exposure?

A lack of visible improvement does not justify exceeding device instructions. Reassess whether the endpoint and expectations fit the evidence, and discuss suitability or persistent concerns with a qualified clinician. The frequency study does not establish a general escalation strategy. [1] [4]

The claim should be as specific as the evidence

Ask for a named outcome, a credible comparison and a relevant study population. That turns “improvement” into something you can evaluate—and keeps a subtle local change from becoming an unsupported promise about your whole face.